Niacin Drug Test Results “a Shocker”

“This is a big deal,” said Steven Nissen, MD, chair of the Tomsich Department of Cardiovascular Medicine at the Cleveland Clinic Miller Family Heart and Vascular Institute, speaking to Margaret Warner on PBS Newshour, May 27, 2011.  He was referring to a recent decision by the NIH to halt testing of a new niacin-based drug.  … Read More

FDA Simvastatin Warning “Overdue”

They call it simvastatin. Trade names Zocor and Vytorin. Millions of Americans take it to lower cholesterol. This week, the FDA slapped a safety restriction on the drug, warning that taking the highest dose, 80 mg., could cause severe muscle injury – especially in the first year of use. As soon as news of the … Read More